Paxel Bio, Foreigners Net Buy 10,813 Shares... Stock Price Up 7.12%
As of 2:30 PM on the 22nd, Baxel Bio is trading at 126,400 KRW, up 7.12% from the previous day. This marks a 41.7% increase compared to February 22.
Today, foreigners have a tentative net purchase of 10,813 shares. Over the past five days, individual investors have net sold 232,047 shares, while foreigners and institutions have net bought 230,986 shares and 4,814 shares, respectively.
On March 19, Baxel Bio was a market topic with the headline, "Will NK cell-based CAR-T therapy surpass others?... Up 0.36."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Given Grants, Then Says "No Launch" ... Innovative Korean Technology Ultimately Forced Overseas
- [Breaking] Chairman Park Sookeun: "Possibility of Agreement Instead of Samsung Electronics Labor-Management Mediation Proposal"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Candy, Yet Impossible to Find... Fears of a 'Pediatric Medical Crisis' as Pharmaceutical Companies Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
